The Cytotoxic Effects of Soybean (Glycine max L.) in Breast Cancer MCF-7 Cell Line In Vitro

Aim of the study: Breast cancer is one of the most noticeable disease in women aged 20-59 years also it is expected to account for 30% of all new cancer diagnoses in women in 2016, Long-term use ofsoybean (Glycine max 1.) may prevent the progression of cancer. However, the molecular mechanism forthe functions of soybean remains unclear. So we decided to see how effective soybeans are on MCF-7Cell lines. Materials and Methods: Human breast cancer cell lines MCF-7 were treated with different concen-trations of methanol extract of soybean seeds. The growth rate was evaluated by XTT tests for 48 and72 hours. Results and Discussion: Soybean showed significant inhibitory effects on the growth rates of MCF-7 cells in a concentration-dependent way (P<0.05). Best efective concentration was 131.65 uM for the 72hours plates on MCF-7 cell lines. result of 48 hours soybeans concentration was calculated as a 476.8 uM. Cytotoxicity assays resulted in a dose dependent growth inhibition of MCF-7 cells. The different concen-tration of soybean will be beneficial to the therapy of breast cancer since its causes may be involved inmultiple aspects. Therefore, soybean methanol extract will necessitate further deep investigation for aprobable use as a cancer preventive food additive.

Erişime Açık
Görüntülenme
6
22.03.2024 tarihinden bu yana
İndirme
1
22.03.2024 tarihinden bu yana
Son Erişim Tarihi
20 Nisan 2024 02:59
Google Kontrol
Tıklayınız
Tam Metin
Tam Metin İndirmek için tıklayın Ön izleme
Detaylı Görünüm
Eser Adı
(dc.title)
The Cytotoxic Effects of Soybean (Glycine max L.) in Breast Cancer MCF-7 Cell Line In Vitro
Yayın Türü
(dc.type)
Sunum
Yazar/lar
(dc.contributor.author)
KOYGUN, Gözde
Yazar/lar
(dc.contributor.author)
ARSLAN, Emine
Yazar/lar
(dc.contributor.author)
GÜLBAHÇE MUTLU, Elif
Atıf Dizini
(dc.source.database)
Diğer
Konu Başlıkları
(dc.subject)
Breast Cancer
Konu Başlıkları
(dc.subject)
XTT Tests
Konu Başlıkları
(dc.subject)
Soybean Glycine Max l
Konu Başlıkları
(dc.subject)
MCF-7
Yayıncı
(dc.publisher)
2nd International UNIDOKAP Black Sea Symposium on Biodıversty
Yayın Tarihi
(dc.date.issued)
2018
Kayıt Giriş Tarihi
(dc.date.accessioned)
2020-01-21T12:25:14Z
Açık Erişim tarihi
(dc.date.available)
2020-01-21T12:25:14Z
Özet
(dc.description.abstract)
Aim of the study: Breast cancer is one of the most noticeable disease in women aged 20-59 years also it is expected to account for 30% of all new cancer diagnoses in women in 2016, Long-term use ofsoybean (Glycine max 1.) may prevent the progression of cancer. However, the molecular mechanism forthe functions of soybean remains unclear. So we decided to see how effective soybeans are on MCF-7Cell lines. Materials and Methods: Human breast cancer cell lines MCF-7 were treated with different concen-trations of methanol extract of soybean seeds. The growth rate was evaluated by XTT tests for 48 and72 hours. Results and Discussion: Soybean showed significant inhibitory effects on the growth rates of MCF-7 cells in a concentration-dependent way (P<0.05). Best efective concentration was 131.65 uM for the 72hours plates on MCF-7 cell lines. result of 48 hours soybeans concentration was calculated as a 476.8 uM. Cytotoxicity assays resulted in a dose dependent growth inhibition of MCF-7 cells. The different concen-tration of soybean will be beneficial to the therapy of breast cancer since its causes may be involved inmultiple aspects. Therefore, soybean methanol extract will necessitate further deep investigation for aprobable use as a cancer preventive food additive.
Tek Biçim Adres
(dc.identifier.uri)
http://hdl.handle.net/20.500.12498/1663
Analizler
Yayın Görüntülenme
Yayın Görüntülenme
Erişilen ülkeler
Erişilen şehirler
6698 sayılı Kişisel Verilerin Korunması Kanunu kapsamında yükümlülüklerimiz ve cerez politikamız hakkında bilgi sahibi olmak için alttaki bağlantıyı kullanabilirsiniz.

creativecommons
Bu site altında yer alan tüm kaynaklar Creative Commons Alıntı-GayriTicari-Türetilemez 4.0 Uluslararası Lisansı ile lisanslanmıştır.
Platforms